Hong Kong stock abnormal movement | Hutchison China MediTech-B (02142.HK) surges over 9% at the closing bell. The company will disclose clinical data on fruquintinib monoclonal antibody therapy at the ESMO Annual Meeting.
According to the Securities Times app, Hebao Pharmaceuticals-B (02142.HK) surged more than 9% in the final trading session, rising 8.95% to HKD 10.35 by the time of publication, with a total turnover of HKD 141 million.
Latest
2 m ago
